Nuvectis Pharma, Inc (NVCT) insider trading
Every open-market stock purchase and sale by Nuvectis Pharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $2.3M over the last 12 months (6 buys).
- Last insider buy: Marlio Charles Mosseri (10% owner), $916K, 4 months ago.
Last 12 months: insiders bought $2.3M (6 buys) and sold $0 (0 sales). Last close $20.70 on Oct 21, 2026.
Recent NVCT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 3, 2026 | Michael J. Carson (President) | Bought (not open market) | — |
| Jun 30, 2026 | Marlio Charles Mosseri (10% owner) | Bought | $916K |
| Jun 30, 2026 | Ron Bentsur (CEO) | Bought | $250K |
| Jun 11, 2026 | James F Oliviero III (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Kenneth Hoberman (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Matthew L. Kaplan (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Juan Sanchez (Director) | Bought (not open market) | — |
| Jan 6, 2026 | Michael J. Carson (President) | Bought (not open market) | — |
| Jan 6, 2026 | Ron Bentsur (CEO) | Bought (not open market) | — |
| Jan 6, 2026 | Enrique Poradosu (Officer) | Bought (not open market) | — |
| Jan 6, 2026 | Shay Shemesh (Officer) | Bought (not open market) | — |
| Nov 5, 2025 | Juan Sanchez (Director) | Bought | $75.3K |
| Nov 5, 2025 | Matthew L. Kaplan (Director) | Bought | $64.2K |
| Nov 5, 2025 | Ron Bentsur (CEO) | Bought | $28.6K |
| Oct 27, 2025 | Marlio Charles Mosseri (10% owner) | Bought | $457K |
| Oct 24, 2025 | Marlio Charles Mosseri (10% owner) | Bought | $215K |
| Oct 23, 2025 | Marlio Charles Mosseri (10% owner) | Bought | $284K |
Who's trading NVCT
- Michael J. Carson, President: other filings, last Aug 3, 2026
- Ron Bentsur, CEO: bought $279K (2 buys), last Jun 30, 2026
- Marlio Charles Mosseri, 10% owner: bought $1.9M (4 buys), last Jun 30, 2026
- Matthew L. Kaplan, Director: bought $64.2K (1 buy), last Jun 11, 2026
- James F Oliviero III, Director: other filings, last Jun 11, 2026
- Juan Sanchez, Director: bought $75.3K (1 buy), last Jun 11, 2026
- Kenneth Hoberman, Director: other filings, last Jun 11, 2026
- Shay Shemesh, Officer: other filings, last Jan 6, 2026
- Enrique Poradosu, Officer: other filings, last Jan 6, 2026
Get free alerts when an insider at Nuvectis Pharma, Inc files a new trade →